Trust Investment Advisors Gsk PLC Transaction History

Trust Investment Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$37.8 - $42.69 $506,897 - $572,472	-13,410 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $9,937 - $10,672	-250 Reduced 1.83%	13,410 $539,000
Q2 2018 Aug 03, 2018	SELL	$39.61 - $42.76 $48,522 - $52,381	-1,225 Reduced 8.23%	13,660 $551,000
Q1 2018 May 29, 2018	SELL	$36.18 - $40.15 $119,394 - $132,495	-3,300 Reduced 18.15%	14,885 $582,000
Q4 2017 Feb 09, 2018	SELL	$35.34 - $41.9 $413,478 - $490,230	-11,700 Reduced 39.15%	18,185 $645,000
Q3 2017 Nov 06, 2017	BUY	$39.44 - $41.55 $1.18 Million - $1.24 Million	29,885	29,885 $1.21 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Trust Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Trust Investment Advisors with notifications on news.